Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior

Child Neuropsychology

Volumn 17, Issue 4, 2011, Pages 313-329

  Payne, Jonathan M ^a   Hyman, Shelley L ^a   Shores, E Arthur ^b   North, Kathryn N ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c University of Sydney   (Australia)

Author keywords

Attention; Ecological validity; Everyday functioning; Executive function; Neurofibromatosis type 1

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION; CASE CONTROL STUDY; CHILD; CHILD BEHAVIOR; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTELLIGENCE TEST; MALE; NEUROFIBROMATOSIS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ATTENTION; CASE-CONTROL STUDIES; CHILD; CHILD BEHAVIOR; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS;

EID: 79960461456     PISSN: 09297049     EISSN: 17444136     Source Type: Journal    
DOI: 10.1080/09297049.2010.542746     Document Type: Article

References (71)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
2. Anderson, V. (1998). Assessing executive functions in children: Biological, psychological, and developmental considerations. Neuropsychological Rehabilitation, 8, 319-349. (Pubitemid 28221454)
3. Anderson, V. A., Anderson, P., Northam, E., Jacobs, R., & Mikiewicz, O. (2002). Relationships between cognitive and behavioral measures of executive function in children with brain disease. Child Neuropsychology, 8, 231-240. (Pubitemid 36577924)
4. Anderson, V., Lajoie, G., & Bell, R. (1995). Neuropsychological assessment of the school-aged child. Melbourne, Australia: Dept. of Psychology University of Melbourne.
5. Baron, I. S. (2007). Behavioural Assessment of the Dysexecutive Syndrome for Children (BADSC) by Emslie, H., Wilson, F. C., Burden, V., Nimmo-Smith, I., & Wilson, B. A. (2003). Child Neuropsychology, 13, 538-542.
6. Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46, 553-563. (Pubitemid 39077137)
7. Bennett, P. C., Ong, B., & Ponsford, J. (2005). Measuring executive dysfunction in an acute rehabilitation setting: Using the Dysexecutive Questionnaire (DEX). Journal of the International Neuropsychological Society, 11, 376-385. (Pubitemid 41167174)
8. Bodnar, L. E., Prahme, M. C., Cutting, L. E., Denckla, M. B., & Mahone, E. M. (2007). Construct validity of parent ratings of inhibitory control. Child Neuropsychology, 13, 345-362. (Pubitemid 46918900)
9. Boll, T. (1997). Children's Category Test. San Antonio, TX: The Psychological Corporation.
10. Burgess, P. W. (1997). Theory and methodology in executive function research. In P. Rabbitt (Ed.), Methodology of frontal and executive function (pp. 81-116). East Sussex, United Kingdom: Psychology Press.
11. Chan, R. C. K., Shum, D., Toulopoulou, T., & Chen, E. Y. H. (2008). Assessment of executive functions: Review of instruments and identification of critical issues. Archives of Clinical Neuropsychology, 23, 201-216.
12. Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13, 181-197. (Pubitemid 39012557)
13. Conners, C. K. (1997). Conners' Rating Scales - Revised. New York, NY: Multi-Health Systems.
14. Denckla, M. B. (2002). The Behavior Rating Inventory of Executive Function: Commentary. Child Neuropsychology, 8, 304-306. (Pubitemid 36577930)
15. Denckla, M. B., & Reiss, A. L. (1997). Prefrontal-subcortical circuits in developmental disorders. In N. A. Krasnegor, G. R. Lyon, & P. S. Goldman-Rakic (Eds.), Development of the prefrontal cortex: Evolution, neurobiology, and behavior (pp. 283-293). Baltimore, MD: Brookes.
16. Dennis, M., Francis, D. J., Cirino, P. T., Schachar, R., Barnes, M. A., & Fletcher, J. M. (2009). Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. Journal of the International Neuropsychological Society, 15, 331-343.
17. Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D. Ward, K., et al. (1996). Children and adolescents with neurofibromatosis 1: A behavioral phenotype. Journal of Developmental & Behavioral Pediatrics, 17, 229-239.
18. Eliason, M. J. (1986). Neurofibromatosis: Implications for learning and behaviour. Journal of Developmental & Behavioral Pediatrics, 7, 175-179.
19. Emslie, H., Wilson, F. C., Burden, V., Nimmo-Smith, I., & Wilson, B. A. (2003). Behavioural Assessment of the Dysexecutive Syndrome in Children. Titchfield, Hants, England: Thames Valley Test.
20. Ferner, R. E. (2007). Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective. Lancet Neurology, 6, 340-351. (Pubitemid 46367948)
21. Gilotty, L., Kenworthy, L., Sirian, L., Black, D. O., & Wagner, A. E. (2002). Adaptive skills and executive function in autism spectrum disorders. Child Neuropsychology, 8, 241-248. (Pubitemid 36577925)
22. Gioia, G., Isquith, P., Guy, S., & Kenworthy, L. (2000). Behavior Rating Inventory of Executive Function- Professional Manual. Odessa, FL: Psychological Assessment Resources.
23. Gioia, G. A., Isquith, P. K., Retzlaff, P. D., & Espy, K. A. (2002). Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychology, 8, 249-257. (Pubitemid 36577926)
24. Gioia, G. A., Isquith, P. K., Retzlaff, P. D., & Pratt, B. M. (2001).Modelling executive functions with everyday behaviors: A unitary or fractionated system? Brain and Cognition, 47, 203-207. (Pubitemid 33732066)
25. Goldstein, G. (1996). Functional considerations in neuropsychology. In R. J. Sbordone & C. J. Long (Eds.), Ecological validity of neuropsychological testing (pp. 75-89). Delray Beach, FL: St. Lucie.
26. Grafman, J., & Litvan, I. (1999). Importance of deficits in executive functions. The Lancet, 354, 1921-1923.
27. Greenwood, R. S., Tupler, L. A., Whitt, J. K., Buu, A., Dombeck, C. B., Harp, A. G., et al. (2005). Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Archives of Neurology, 62, 1904-1908. (Pubitemid 41785084)
28. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65-70.
29. Hongwanishkul, D., Happaney, K. R., Lee, W. S. C., & Zelazo, P. D. (2005). Assessment of hot and cool executive function in young children: Age-related changes and individual differences. Developmental Neuropsychology, 28, 617-644. (Pubitemid 41368245)
30. Huson, S. M., & Hughes, R. A. C. (1994). The neurofibromatoses: A pathogenetic and clinical overview. London, United Kingdom: Chapman and Hall.
31. Hyman, S. L., Gill, D. S., Shores, E. A., Steinberg, A., & North, K. N. (2007). T2-Hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. Journal of Neurology, Neurosurgery & Psychiatry, 78, 1088-1091.
32. Hyman, S. L., Shores, E. A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65, 1037-1044. (Pubitemid 41429628)
33. Kayl, A. E., & Moore, B. D. (2000). Behavioral phenotype of neurofibromatosis, type 1. Mental Retardation & Developmental Disabilities Research Reviews, 6, 117-124. (Pubitemid 30399534)
34. Kayl, A. E., Moore, B. D., Slopis, J. M., Jackson, E. F., & Leeds, N. E. (2000). Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. Journal of Child Neurology, 15, 90-96. (Pubitemid 30139872)
35. Kerr, A., & Zelazo, P. D. (2004). Development of "hot" executive function: The Children's Gambling Task. Brain and Cognition, 55, 148-157. (Pubitemid 38591436)
36. Korkman, M., Kirk, U., & Kemp, S. (1998). NEPSY: A Developmental Neuropsychological Assessment- Manual. New York, NY: Psychological Corporation.
37. Koth, C. W., Cutting, L. E., & Denckla, M. B. (2000). The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychology, 6, 185-194.
38. Krab, L. C., de Goede-Bolder A., Aarsen, F. K., Pluijm, S. M. F., Bouman, M. J., van der Geest, J., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial. Journal of the American Medical Association, 300, 287-294. (Pubitemid 352008645)
39. Krikorian, R., Bartok, J., & Gay, N. (1994). Tower of London procedure: Standard method and developmental data. Journal of Clinical & Experimental Neuropsychology, 16, 840-850. (Pubitemid 24371583)
40. Levine, T. S., Materek, A., Abel, J., O'Donnell, M., & Cutting, L. E. (2006). Cognitive profile of neurofibromatosis type 1. Seminars in Pediatric Neurology, 13, 8-20. (Pubitemid 43963396)
41. Long, C. J., & Collins, L. F. (1997). Ecological validity and forensic neuropsychological assessment. In R. J. McCaffrey, A. D. Williams, J. M. Fisher, & L. C. Laing (Eds.), The practice of forensic neuropsychology: Meeting challenges in the courtroom (pp. 153-164). New York, NY: Plenum.
42. Lord, F. M. (1967). A paradox in the interpretation of group comparisons. Psychological Bulletin, 68, 304-305.
43. Mangeot, S., Armstrong, K., Colvin, A. N., Yeates, K. O., & Taylor, G. (2002). Long-term executive function deficits in children with traumatic brain injuries: Assessment using the Behavior Rating Inventory of Executive Function (BRIEF). Child Neuropsychology, 8, 271-284. (Pubitemid 36577928)
44. Manly, T., Robertson, I. H., Anderson, V., & Nimmo-Smith, I. (1999). The Test of Everyday Attention for Children. London, United Kingdom: Battley Brothers.
45. Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44, 164-170. (Pubitemid 34232373)
46. Mazzocco, M. M. M., Turner, J. E., Denckla, M. B., Hofman, K. J., Scalon, D. C., & Vellutino, F. R. (1995). Language and reading deficits associated with neurofibromatosis type 1: Evidence for a not-so-nonverbal learning disability. Developmental Neuropsychology, 11, 503-522.
47. McCandless, S., & O'Laughlin, L. (2007). The clinical utility of the Behavior Rating Inventory of Executive Function (BRIEF) in the diagnosis of ADHD. Journal of Attention Disorders, 10, 381-389.
48. McCue, M., & Pramuka, M. (1998). Functional assessment. In G. Goldstein, & S. Beers (Eds.), Rehabilitation (pp. 113-129). New York, NY: Plenum.
49. Moore, B. D., Ater, J. L., Needle, M. N., Slopis, J., & Copeland, D. R. (1994). Neuropsychological profile of children with neurofibromatosis, brain tumor or both. Journal of Child Neurology, 9, 368-377.
50. Moore, B. D., Slopis, J. M., Jackson E. F., de Winter, A. E., & Leeds, N. E. (2000). Brain volume in children with neurofibromatosis type 1: Relation to neuropsychological status. Neurology, 54, 914-920. (Pubitemid 30111352)
51. Murray, D. W., Kollins, S. H., Hardy, K. K., Abikoff, H. B., Swanson, J. M., Cunningham, C., et al. (2007). Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). Journal of Child and Adolescent Psychopharmacology, 17, 605-619. (Pubitemid 350058981)
52. National Institutes of Health Consensus Development Conference. (1988). Neurofibromatosis Conference Statement. Archives of Neurology, 45, 575-578.
53. North, K. (1997). Neurofibromatosis type 1 in childhood. London, United Kingdom: Mac Keith.
54. North, K., Joy, P., Yuille, D., Cocks, N., & Hutchins, P. (1995). Cognitive function and academic performance in children with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 37, 427-436.
55. Papageorgiou, V., Kalyva, E., Dafoulis, V., & Vostanis, P. (2008). Differences in parents' and teachers' ratings of ADHD symptoms and other mental health problems. European Journal of Psychiatry, 22, 200-210.
56. Payne, J. M., Moharir, M. D., Webster, R., & North, K. N. (2010). Brain structure and function in neurofibromatosis type 1: Current concepts and future directions. Journal of Neurology, Neurosurgery & Psychiatry, 81, 304-309.
57. Prencipe, A., & Zelazo, P. D. (2005). Development of affective decision-making for self and other: Evidence for the integration of first- and third-person perspectives. Psychological Science, 16, 501-505. (Pubitemid 41186739)
58. Pride, N., Payne, J. M., Webster, R., Shores, E. A., Rae, C., & North, K. N. (2010). Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1. Journal of Child Neurology, 25, 834-841.
59. Rowbotham, I., Pit-ten Cate, I. M., Sonuga-Barke, E. J. S., & Huijbregts, S. C. J. (2009). Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology, 23, 50-60.
60. Sbordone, R. J. (1996). Ecological validity: Some critical issues for the neuropsychologist. In R. J. Sbordone & C. J. Long (Eds.), Ecological validity of neuropsychological testing (pp. 1-14). Delray Beach, FL: St. Lucie.
61. Shallice, T., & Burgess, P. W. (1991). Deficits in strategy application following frontal lobe damage in man. Brain, 114, 727-741.
62. Shilyanski, C., Lee, Y. S., & Silva, A. J. (2010). Molecular and cellular mechanisms of learning and disabilities: A focus on NF1. Annual Review of Neuroscience, 33, 221-243.
63. Stuss, D. T., & Alexander, M. P. (2000). Executive functions and the frontal lobes: A conceptual view. Psychological Research, 63, 289-298.
64. Toplak, M. E., Bucciarelli, S. M., Jain, U., & Tannock, R. (2009). Executive functions: Performance-based measures and the Behavior Rating Inventory of Executive Function. Child Neuropsychology, 15, 53-72.
65. Verdejo-Garcia, A., & Perez-Garcia, M. (2007). Ecological validity of executive functions in substance dependent individuals. Drug and Alcohol Dependence, 90, 48-55. (Pubitemid 46935373)
66. Wechsler, D. (1991). Wechsler Intelligence Scale for Children (3rd ed.). New York, NY: The Psychological Corporation.
67. Wechsler, D. (2003). Wechsler Intelligence Scale for Children (4th ed.). San Antonio, TX: The Psychological Corporation.
68. Weiss, B., Bollag, G., & Shannon, K. (1999). Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. American Journal of Medical Genetics Part C, 89, 14-22. (Pubitemid 30033172)
69. Wilson, B. A., Alderman, N., Burgess, P., Emslie, H., & Evans, J. (1996). Behavioural Assessment of the Dysexecutive Syndrome. Bury St. Edmunds, United Kingdom: Thames Valley Test Company.
70. Wood, R. L., & Liossi, C. (2006). The ecological validity of executive tests in a severely brain injured sample. Archives of Clinical Neuropsychology, 25, 429-437. (Pubitemid 44247521)
71. Young, H., Hyman, S. L., & North, K. (2002). Neurofibromatosis type 1: Clinical manifestations and exceptions to the rule. Journal of Child Neurology, 17, 624-632.